|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào):S142520 |
| 產(chǎn)品名稱:SarTATE |
| 產(chǎn)品CAS:1518779-60-6 |
| 規(guī)格含量:2.5mg |
| 產(chǎn)品價(jià)格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
S142520 |
| 名稱: |
SarTATE |
| 別名: |
(2S,3R)-2-((4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-((R)-1-hydroxyethyl)-19-((R)-2-(5-((8-methyl-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosan-1-yl)amino)-5-oxopentanamido)-3-phenylpropanamido)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamido)-3-hydroxybutanoic Acid |
| CAS號(hào): |
1518779-60-6 |
| 分子式: |
C??H???N??O??S? |
| 分子量: |
1458.79 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
SarTATE is a novel radiopharmaceutical compound for treating cancer. |
| 參考文獻(xiàn) |
|
|
|
|